Listing in London – King & Spalding carries US biotech to AIM listing

Legal Business · 11 May 2015 · 1 min read

Corporate and M&A US Covington & Burling K&L Gates King & Spalding

King & Spalding’s recent recruits in the City have helped handle Californian biotech company Verseon £300m stock market listing in London while Covington & Burling advised from San Francisco.

This article is for Legal Business subscribers. Please log in or subscribe to read on.

Related Content

The $110bn Paramount-Warner Bros mega-merger: all the law firms involved

Revolving Doors: HSF Kramer hires Sidley life sciences head as Ashurst Perkins Coie sees further departures

Trading Places: Gibson Dunn picks up Paul Weiss disputes trio as Latham finance pair move to V&E

Cravath makes rare London partner promotion amid 11-strong round

Sidley in talks to take Weil Paris office alongside heavyweight PE partners in London and Germany

Slaughters leads for Anthropic on UK share offer in IPO

Clifford Chance names Cohen first New York managing partner amid fresh bid to crack America with Houston office opening

International Women’s Day 2022: Barbara L. Becker, chair & managing partner, Gibson Dunn, New York

International Women’s Day 2022: Perlette Jura, Gibson Dunn, Los Angeles – disputes